The market for retinopathy in preterm infants is expected to grow by leaps and bounds in the coming years. As digital convergence emerges as a linchpin, the entire ecosystem including OEMs, vendors, payers, and various other intermediaries is in orbit. These value-based, end-user-centric models take center stage. SMAC and IoT are used to build scalable, connected digital platforms. This is the ongoing trend and is expected to continue during the forecast period. The most common and serious complication that threatens vision is retinopathy of prematurity in newborns. Gestational age is the main factor leading to retinopathy in preterm infants. The WHO estimates that there are around 15 million preterm births each year.
About 14,000 are affected by retinopathy of prematurity, and 90% of those affected by retinopathy of prematurity have only mild disease. Aside from low birth weight, other factors associated with the presence of ROP are anemia, poor weight gain, blood transfusion, shortness of breath, difficulty breathing.
Get sample copy of this report at https://www.persistencemarketresearch.com/samples/31397
About 14,000-16,000 of these infants are affected by some degree of ROP. However, infants with a more severe condition may develop vision problems or even blindness. About 1,100-1,500 infants annually develop retinopathy of prematurity severe enough to require medical treatment.
In the United States, approximately 400-600 infants go blind each year due to retinopathy of prematurity. In addition, the modernization of healthcare infrastructure along with the growing demand for early detection systems are some of the driving forces for retinopathy in preterm infants.
The clinical pipeline for retinopathy of prematurity also appears to be full of promise, with many drugs specifically targeting retinopathy of prematurity. However, a shortage of skilled ophthalmologists coupled with poor primary infrastructure and a lack of insurance facilities are restraining the growth of the global diabetic retinopathy market.
TOC Request @ https://www.persistencemarketresearch.com/toc/31397
The global retinopathy of prematurity market is segmented by disease type, treatment type, and end-user.
Based on indication, the global retinopathy of prematurity market can be segmented as follows:
- Extraretinal fibrovascular proliferation
- Partial retinal detachment
- Total retinal detachment
Based on treatment type, the global retinopathy of prematurity market can be segmented as follows:
- oxygen therapies
- laser treatment
- cryotherapy
- anti-VEGF
- Biologics (eg, bevacizumab)
Based on end-user, the global retinopathy of prematurity market can be segmented as follows:
- hospitals
- eye clinics
- Ambulatory Surgical Centers
Get a customized scope that suits your needs. Ask an Expert – sales@persistencemarketresearch.com
The segment of partial retinal detachment in retinopathy of prematurity is highly valued as it is the most common stage of retinopathy in preterm infants. Rising health awareness are the factors that will boost the growth of the global retinopathy of prematurity market in the coming years.
Based on the type of treatment, laser therapy is valued in the retinopathy of prematurity market as the treatment has shown the most effective results. However, there is a need to develop an inexpensive and easy-to-use laser treatment.
In this way, way is covered to satisfy various unmet needs in the diabetic retinopathy market which is projected to grow at a great pace in the coming 20 years. Based on distribution, the global vitamin B12 deficiency treatment market will be dominated by hospitals in the coming years.
Access the full report at https://www.persistencemarketresearch.com/checkout/31397
Regionally, the global retinopathy of prematurity market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. Among all regions, North America dominated the market, followed by Europe.
The factors attributable to North America and Europe are high preterm birth rates, while Asia is expected to show the booming growth in the next five years. Within the Asian region, the Western Pacific is responsible for a greater proportion of neonatal blindness due to retinopathy compared to Southeast Asia.
The main factors contributing to the increasing proportion of retinopathy of prematurity in emerging economies are large numbers of infants and increasing government support and funding.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com